Xencor, Inc.
XNCRBiotechnology
$29.21−2.60%As of Oct 29vs prior close
- Market cap
- $2.2B
- P/E (TTM)
- –
- From 52W high
- −2.60%
- EPS (LTM)
- -$2.17
- Revenue (LTM)
- $105M
- Net margin
- -155.59%
- Dividend yield
- 0.00%
Nomior Score
46
Emerging BreakoutSpeculativeBottom 42% of the scored universe
Growth38
Quality43
Value51
Momentum79
Resilience33
Growth
+1.58%revenue a year over 9 fiscal years
YE16 $109MLTM $105M
Connections
Revenue to profitQ2 YE26
The operating loss was 72% of revenue, narrower by 4 pts on a year.
Who owns it
2funds